Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066 in Advanced Parkinson's Disease

NCT01130493 is registered in ClinicalTrials.gov with Impax Laboratories, LLC as lead sponsor.

NCT NCT01130493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01130493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066 in Advanced Parkinson's Disease
Lead sponsor
Impax Laboratories, LLC
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2010
Completion date
January 31, 2012
Enrollment
110 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease